Antibiotic resistance to a superbug that causes cancer has more than doubled in just 20 years, according to new research.   The finding is based on drugs that treat Helicobacter pylori – a potentially deadly bacteria linked to peptic ulcers and the gastric tumour lymphoma.

 

Read more…